Nucleus. In patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis Antibodies

Nucleus. In patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis

PARTNERSHIP OPPORTUNITIES

NeoBiotechnologies holds Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.

LETS TALK